63 results
Page 3 of 4
8-K
v193l 09o
29 Sep 20
Evolent Health to Detail Progress on Profitable Organic Growth Strategy at Virtual Investor Day
8:12am
8-K
EX-10.1
zx571h5q0qazal jkp7a
25 Aug 20
Entry into a Material Definitive Agreement
4:56pm
DEFA14A
1nz2mb
29 Apr 20
Additional proxy soliciting materials
4:12pm
8-K
eybs 4ia1mii31pkb3
15 Jan 20
Regulation FD Disclosure
10:09am
8-K
EX-10.1
456pugucb0dy0o jdss
31 Dec 19
Entry into a Material Definitive Agreement
8:12am
8-K
EX-10.2
8ep4op21wd kzn
31 Dec 19
Entry into a Material Definitive Agreement
8:12am
D
lu0o16 oxavzweu9
28 Jun 19
$1.3M in equity, sold $1.3M, 18 investors
4:31pm
DEFA14A
3tx612 9o7
30 Apr 19
Additional proxy soliciting materials
4:39pm
8-K
EX-10.1
0hts1 41bpk85t1stx6
22 Oct 18
Entry into a Material Definitive Agreement
9:58pm
D
90cy8aq6epsh1e9vx
16 Oct 18
$88.88M in equity, sold $83.17M, 18 investors
12:10pm
DEFA14A
hdukwuckqq d196i1c
27 Apr 18
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
73wqh0u3hq 63e4
14 Jul 16
Evolent Health to Acquire Valence Health, Extending Breadth and Depth
12:00am
10-K
e8cm oau41div
29 Feb 16
Annual report
12:00am